Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Multicentre Observational Study on Risk Factors for Breast Cancer.
Khadilkar S, Bopanna M, Parab P, Gulia S, Chhasatia S, Kothari S, Gogineni S, Taneja T, Perumal P, Jethwa D, Kembhavi Y, Gupta S. Khadilkar S, et al. Among authors: kembhavi y. J Obstet Gynaecol India. 2020 Oct;70(5):371-375. doi: 10.1007/s13224-020-01330-8. Epub 2020 Jul 10. J Obstet Gynaecol India. 2020. PMID: 33041555 Free PMC article.
Survival outcomes with 12 weeks of adjuvant or neoadjuvant trastuzumab in breast cancer.
Ghosh J, Joy Phillip DS, Ghosh J, Bajpai J, Gulia S, Parmar V, Nair N, Joshi S, Sarin R, Budrukkar AN, Wadasadawala T, Desai SB, Shet T, Patil A, Sawant SP, Dhir AA, Kembhavi S, Popat P, Hawaldar R, Kembhavi Y, Perumal P, Banavali SD, Badwe RA, Gupta S. Ghosh J, et al. Among authors: kembhavi y. Indian J Cancer. 2022 Jul-Sep;59(3):387-393. doi: 10.4103/ijc.IJC_850_19. Indian J Cancer. 2022. PMID: 33753616 Free article. Clinical Trial.
Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice.
Rath S, Elamarthi P, Parab P, Gulia S, Nandhana R, Mokal S, Kembhavi Y, Perumal P, Bajpai J, Ghosh J, Gupta S. Rath S, et al. Among authors: kembhavi y. PLoS One. 2021 Jul 22;16(7):e0253722. doi: 10.1371/journal.pone.0253722. eCollection 2021. PLoS One. 2021. PMID: 34292933 Free PMC article.
Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
Gupta S, Maheshwari A, Parab P, Mahantshetty U, Hawaldar R, Sastri Chopra S, Kerkar R, Engineer R, Tongaonkar H, Ghosh J, Gulia S, Kumar N, Shylasree TS, Gawade R, Kembhavi Y, Gaikar M, Menon S, Thakur M, Shrivastava S, Badwe R. Gupta S, et al. Among authors: kembhavi y. J Clin Oncol. 2018 Jun 1;36(16):1548-1555. doi: 10.1200/JCO.2017.75.9985. Epub 2018 Feb 12. J Clin Oncol. 2018. PMID: 29432076 Clinical Trial.
Translation and validation of European Organization for Research and Treatment for Cancer quality of life questionnaire-OV-28 module into Indian languages (Hindi and Marathi) to study quality of life of ovarian cancer patients from a tertiary care cancer center.
Bajpai J, Panda PK, Kagwade S, Govilkar M, Velaskar S, Kembhavi Y, Gupta S, Ghosh J, Deodhar J. Bajpai J, et al. Among authors: kembhavi y. South Asian J Cancer. 2018 Jan-Mar;7(1):37-41. doi: 10.4103/sajc.sajc_240_17. South Asian J Cancer. 2018. PMID: 29600233 Free PMC article.
Ten-year follow-up of outcomes, patterns of care, and psychosocial burden in adolescent and young adult (AYA) patients with bone sarcomas from a large cohort in a low-income and middle-income country (LMIC).
Bajpai J, Sarkar L, Rath S, Chandrasekharan A, Panda G, Jakar D, Pawar A, Ghosh J, Laskar S, Rekhi B, Khanna N, Manjali JJ, Ramadwar M, Purandare N, Bhargava P, Chakrabarty N, Gala K, Kembhavi Y, Rangarajan V, Banavali S, Gupta S. Bajpai J, et al. Among authors: kembhavi y. Cancer. 2024 Sep 19. doi: 10.1002/cncr.35547. Online ahead of print. Cancer. 2024. PMID: 39297373
11 results